- Home
- OOMA vs EIKN Comparison
OOMA vs EIKN Comparison
Compare OOMA & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OOMA | EIKN |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 565.7M | 631.0M |
| IPO Year | 2015 | 2026 |
Fundamental Metrics
Financial Performance| Metric | OOMA | EIKN |
|---|---|---|
| Price | $21.00 | $7.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $26.60 | $24.60 |
| AVG Volume (30 Days) | 416.7K | ★ 582.7K |
| Earning Date | 08-26-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 188.46 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $114,490,000.00 | N/A |
| Revenue This Year | $21.68 | N/A |
| Revenue Next Year | $4.82 | N/A |
| P/E Ratio | $103.80 | ★ N/A |
| Revenue Growth | ★ 9.53 | N/A |
| 52 Week Low | $9.79 | $7.40 |
| 52 Week High | $26.19 | $16.50 |
Technical Indicators
Market Signals| Indicator | OOMA | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 40.81 | 34.22 |
| Support Level | $19.66 | N/A |
| Resistance Level | $21.57 | $10.20 |
| Average True Range (ATR) | 0.84 | 0.67 |
| MACD | -0.26 | -0.11 |
| Stochastic Oscillator | 22.93 | 15.97 |
Price Performance
Historical ComparisonAbout OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.